Coldstream Capital Management Inc Tyra Biosciences, Inc. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 28 shares of TYRA stock, worth $294. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28Holding current value
$294% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TYRA
# of Institutions
117Shares Held
44.4MCall Options Held
14.6KPut Options Held
6K-
Ra Capital Management, L.P. Boston, MA10.6MShares$112 Million2.39% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA4.14MShares$43.5 Million95.26% of portfolio
-
Alta Partners Management Company, L.P. Jackson, WY4.08MShares$42.8 Million90.83% of portfolio
-
Nextech Invest Ag4.06MShares$42.6 Million10.51% of portfolio
-
Bvf Inc San Francisco, CA3.94MShares$41.4 Million2.05% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $441M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...